NCT05987683

Brief Summary

Myofascial pain is characterized by myofascial trigger points, considered as a major cause of neck and shoulder pain in the working population. Thread-embedding acupuncture is a new acupuncture modality that can provide long-term stimulation aimed at prolonging its therapeutic effect that is similar to conventional acupuncture, such as analgesic effects. The goal of this randomized controlled trial is to evaluate and compare the effects of thread-embedding acupuncture and sham thread-embedding acupuncture as a therapy for myofascial pain in the upper trapezius muscle. The primary aim of this study is to investigate whether thread-embedding acupuncture therapy gives better and last longer results for myofascial pain of the upper trapezius muscle than sham thread-embedding acupuncture.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

August 21, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

December 27, 2023

Status Verified

December 1, 2023

Enrollment Period

2 months

First QC Date

July 26, 2023

Last Update Submit

December 20, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale

    Pain rating scale for measuring pain

    before treatment (baseline) and 3 days, 1 week, 4 weeks, 8 weeks after treatment

Secondary Outcomes (2)

  • Neck Disability Index

    before treatment (baseline) and 3 days, 1 week, 4 weeks, 8 weeks after treatment

  • Pressure Pain Threshold

    before treatment (baseline) and 3 days, 1 week, 4 weeks, 8 weeks after treatment

Study Arms (2)

Thread-Embedding Acupuncture

EXPERIMENTAL

Thread-Embedding Acupuncture using a 29-gauge TEA needle with a 50-mm PDO (polydioxanone) thread

Procedure: Thread-Embedding Acupuncture, Sham Thread-Embedding Acupuncture

Sham Thread-Embedding Acupuncture

SHAM COMPARATOR

Sham Thread-Embedding Acupuncture using a 29-gauge TEA needle but thread-removed, just needle alone

Procedure: Thread-Embedding Acupuncture, Sham Thread-Embedding Acupuncture

Interventions

Thread-Embedding Acupuncture: using a 29-gauge TEA needle with a 50-mm PDO (polydioxanone) thread Sham Thread-Embedding Acupuncture: using a 29-gauge TEA needle but thread-removed, just needle alone

Sham Thread-Embedding AcupunctureThread-Embedding Acupuncture

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female aged 18-59 years.
  • Subject with myofascial pain in the upper trapezius muscle.
  • VAS score of 30-70 mm from 100 mm during activities (everyday activities or light exercise).
  • Pain \> 3 months.
  • Willing to participate in this research to completion and sign informed consent.

You may not qualify if:

  • Fibromyalgia.
  • Have had cervical spine surgery.
  • Have done Dry needling therapy on the upper trapezius muscle in the last 9 days
  • Have done thread acupuncture on the upper trapezius muscle in the last 6 months.
  • Have performed pharmacopuncture on the upper trapezius muscle in the last 6 months.
  • VAS score is more than 70 mm than 100 mm at resting.
  • History of anti-inflammatory drug treatment in the previous 2 weeks.
  • History of intra-articular steroid injections in the previous 3 months.
  • There is a tumor, wound, or skin infection at the needle insertion area.
  • Fever (≥ 37.5 oC).
  • There is a hypersensitivity reaction in previous acupuncture therapy (metal allergy, severe atopy, keloids, or other skin hypersensitivity).
  • Suffering from a blood disorder or taking blood thinners (anti-platelet or anti-coagulant drugs).
  • Have a heart condition or uncontrolled diabetes.
  • Blood glucose level (GDS) ≥200 mg/dL is checked by capillary blood using a glucometer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cipto Mangunkusumo Hospital

Jakarta, DKI Jakarta, 10430, Indonesia

Location

Persahabatan Hospital

Jakarta, DKI Jakarta, 13230, Indonesia

Location

Study Officials

  • KEPK FKUI-RSCM

    The Ethics Committee of the Faculty of Medicine, University of Indonesia - Cipto Mangunkusumo Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

July 26, 2023

First Posted

August 14, 2023

Study Start

August 21, 2023

Primary Completion

October 31, 2023

Study Completion

October 31, 2023

Last Updated

December 27, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations